By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Levosulpiride and Rabeprazole are used together in a treatment. It is an anti-reflux medication that is used to treat GERD, also known as gastrointestinal reflux disease. It is a condition in which stomach acid reaches the food pipe and causes acidity, heartburn, and other symptoms.
Levosulpiride and Rabeprazole are available as tablets and capsules. Before starting this medication, tell your doctor if you are breastfeeding, planning to become pregnant, or taking any other medications or supplements, as well as any conditions or diseases you have.
Rabeprazole works by blocking the secretion of acid in the stomach by acting on a pump called the proton pump in the stomach, responsible for the secretion of stomach acids.
Levosulpiride works by increasing the motility of the stomach and intestine so that acid does not reflux back into the food pipe.
The Global levosulpiride rabeprazole market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Cyra LS – Among the medications known as gastrointestinal agents, Levosulpirid e+ rabeprazole is used to treat GERD, acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers, and GERD.
A mucous layer usually shields the stomach from acid. The mucous layer can sometimes be eroded by excessive acid production, resulting in acidity.
Levosulpiride+rabeprazole consists of two medications: Levosulpiride, an antiproton pump inhibitor, and rabeprazole Rabeprazole prevents acid production by inhibiting an enzyme known as the gastric proton pump.
Levosulpiride prevents acid and food from backflowing into the mouth by raising the pressure of the inferior oesophageal sphincter. The combination of LEVOSULPIRIDE and RABEPRAZOLE alleviates acidity and heartburn by preventing acid reflux.
Levosulpiride + rabeprazole may interact with a blood thinner (warfarin), anti-cancer (methotrexate), cardiac glycoside (digoxin), immunosuppressant (mycophenolate mofetil, tacrolimus), antibiotic (amoxicillin, clarithromycin).
LEVOSULPIRIDE+RABEPRAZOLE may cause osteoporosis (weak and brittle bones) and hypomagnesemia (low magnesium levels) on long-term treatment. Consult a doctor if you are pregnant or breastfeeding.
LEVOSULPIRIDE+RABEPRAZOLE may cause dizziness and drowsiness, On long-term treatment, LEVOSULPIRIDE+RABEPRAZOLE may cause osteoporosis and hypomagnesemia.
The person might experience certain common side-effects such as headache, nausea, vomiting, gas, abdominal pain, dizziness, and diarrhoea. Most of these side effects do not require medical attention and will resolve gradually over time.
